These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 8609341

  • 1. Transplant candidates with severe left ventricular dysfunction managed with medical treatment: characteristics and survival.
    Rickenbacher PR, Trindade PT, Haywood GA, Vagelos RH, Schroeder JS, Willson K, Prikazsky L, Fowler MB.
    J Am Coll Cardiol; 1996 Apr; 27(5):1192-7. PubMed ID: 8609341
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Restrictive criteria for heart transplantation candidacy maximize survival of patients with advanced heart failure.
    Frigerio M, Gronda EG, Mangiavacchi M, Andreuzzi B, Colombo T, De Vita C, Oliva F, Quaini E, Pellegrini A.
    J Heart Lung Transplant; 1997 Feb; 16(2):160-8. PubMed ID: 9059927
    [Abstract] [Full Text] [Related]

  • 4. [Prognosis of heart transplant candidates stabilized on medical therapy].
    Fernández-Yáñez J, Palomo J, Torrecilla EG, Pascual D, Garrido G, Gómez de Diego JJ, Domínguez M, Almendral J.
    Rev Esp Cardiol; 2005 Oct; 58(10):1162-70. PubMed ID: 16238984
    [Abstract] [Full Text] [Related]

  • 5. Diastolic filling pattern and left ventricular diameter predict response and prognosis after cardiac resynchronisation therapy.
    Gradaus R, Stuckenborg V, Löher A, Köbe J, Reinke F, Gunia S, Vahlhaus C, Breithardt G, Bruch C.
    Heart; 2008 Aug; 94(8):1026-31. PubMed ID: 17984216
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Mid-term results of heart transplantation, cardiomyoplasty, and medical treatment of refractory heart failure caused by idiopathic dilated cardiomyopathy.
    Bocchi EA, Bellotti G, Moreira LF, Bacal F, de Moraes AV, Fiorelli A, Mansur A, Stolf N, Jatene A, Pileggi F.
    J Heart Lung Transplant; 1996 Jul; 15(7):736-45. PubMed ID: 8820791
    [Abstract] [Full Text] [Related]

  • 8. Prostaglandin E1 testing in heart failure-associated pulmonary hypertension enables transplantation: the PROPHET study.
    von Scheidt W, Costard-Jaeckle A, Stempfle HU, Deng MC, Schwaab B, Haaff B, Naegele H, Mohacsi P, Trautnitz M, PROPHET Study Group.
    J Heart Lung Transplant; 2006 Sep; 25(9):1070-6. PubMed ID: 16962468
    [Abstract] [Full Text] [Related]

  • 9. [Hemodynamics and clinical data in chronic coronary disease with severe left ventricular systolic dysfunction].
    Marinato PG, Dametto E, Maragno I, Razzolini R, Chinellato P, Santostasi G, Dalla Volta S.
    Cardiologia; 1996 Apr; 41(4):349-59. PubMed ID: 8674104
    [Abstract] [Full Text] [Related]

  • 10. Study of muscular and ventricular function in dynamic cardiomyoplasty: a ten-year follow-up.
    Chachques JC, Berrebi A, Hernigou A, Cohen-Solal A, Lavergne T, Marino JP, D'Attellis N, Bensasson D, Carpentier A.
    J Heart Lung Transplant; 1997 Aug; 16(8):854-68. PubMed ID: 9286778
    [Abstract] [Full Text] [Related]

  • 11. Dynamic cardiomyoplasty at seven years.
    Carpentier A, Chachques JC, Acar C, Relland J, Mihaileanu S, Bensasson D, Kieffer JP, Guibourt P, Tournay D, Roussin I.
    J Thorac Cardiovasc Surg; 1993 Jul; 106(1):42-52; discussion 52-4. PubMed ID: 8321004
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Left ventricular end-diastolic volume index, age, and maximum heart rate at peak exercise predict survival in patients referred for heart transplantation.
    Koelling TM, Semigran MJ, Mijller-Ehmsen J, Schmidt U, Mathier MA, Dec GW, Di Salvo TG.
    J Heart Lung Transplant; 1998 Mar; 17(3):278-87. PubMed ID: 9563604
    [Abstract] [Full Text] [Related]

  • 15. Major adverse cardiac event predictors in survivors of myocardial infarction with asymptomatic left ventricular dysfunction or chronic heart failure.
    Kuch M, Janiszewski M, Mamcarz A, Cudnoch-Jedrzejewska A, Dłuzniewski M.
    Med Sci Monit; 2009 Jun; 15(6):PH40-8. PubMed ID: 19478711
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Low-dose dobutamine responsiveness in idiopathic dilated cardiomyopathy: relation to exercise capacity and clinical outcome.
    Scrutinio D, Napoli V, Passantino A, Ricci A, Lagioia R, Rizzon P.
    Eur Heart J; 2000 Jun; 21(11):927-34. PubMed ID: 10806017
    [Abstract] [Full Text] [Related]

  • 18. Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction.
    Williams MJ, Odabashian J, Lauer MS, Thomas JD, Marwick TH.
    J Am Coll Cardiol; 1996 Jan; 27(1):132-9. PubMed ID: 8522686
    [Abstract] [Full Text] [Related]

  • 19. Coronary artery bypass grafting in patients with severe left ventricular dysfunction--early and mid-term outcomes.
    Shapira OM, Hunter CT, Anter E, Bao Y, DeAndrade K, Lazar HL, Shemin RJ.
    J Card Surg; 2006 Jan; 21(3):225-32. PubMed ID: 16684046
    [Abstract] [Full Text] [Related]

  • 20. Feasibility, safety, and mid-term efficacy of cardiac resynchronization therapy in patients with severe heart failure and ventricular conduction delay: Chulalongkorn experience.
    Sunsaneewitayakul B, Sitthisook S, Sangwatanaroj S, Prechawat S, Songmuang SB.
    J Med Assoc Thai; 2007 Jul; 90(7):1458-66. PubMed ID: 17710992
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.